Drug class
Oral triterpenoid antifungal; fungal 1,3-beta-D-glucan synthase inhibitor
Mechanism of action
Inhibits fungal 1,3-beta-D-glucan synthase, disrupting synthesis of an essential component of the fungal cell wall and causing structural instability and cell death.
General use cases
- Treatment of vulvovaginal candidiasis (VVC) in adult and postmenarchal paediatric patients
- Reduction in the incidence of recurrent vulvovaginal candidiasis in adult and postmenarchal paediatric patients after treatment of the current episode; regimen and indication are product-label specific
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
